Obigen Pharma Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 6, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Debt / Equity Ratio	0.06	0.06	0.06	0.04
Net Debt / Equity Ratio	-0.37	-0.39	-0.43	-0.25
Net Debt / EBITDA Ratio	2.91	3.46	5.20	2.96
Net Debt / FCF Ratio	3.37	3.92	6.54	1.33
Quick Ratio	24.00	22.32	39.29	25.05
Current Ratio	24.54	22.42	42.26	28.78
Return on Equity (ROE)	-	-15.21%	-14.36%	-
Return on Assets (ROA)	-	-9.35%	-8.84%	-
Return on Capital Employed (ROCE)	-18.10%	-16.40%	-12.60%	-14.30%
Buyback Yield / Dilution	-39.47%	-3.45%	-34.82%	-

Source: S&P Capital IQ. Standard template. Financial Sources.